Skip to main content

Table 1 Gene lists based on various selection criteria from the 43 DEGs in COX-2 high patients

From: Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition

Selection criteria High genetic alteration in TCGA-TNBC patients (GL1) High genetic alteration in MBC patients (GL2) High mRNA expression in PAM50 basal BC patients (GL3) High Mrna expression in TNBC patients (GL4) High expression correlates with poor survival outcomes (GL5) High expression in COX-2 inhibitor-resistant BC cell lines (GL6)
Gene symbol MDFI
EPHB3
FBXO32
MSN
SFRP1
ID4
ACTN4
TNFRSF21
MFGE8
TFAP2C
RGS2
ITGB4
SLC44A2
ITGA6
S100B
KLK7
DEGS1
GNAS
PTGS2
LAMC2
KLK5
TACSTD2
SLC2A1
CTNNB1
KLK6
CD55
TPM4
FURIN
RBP1
KRT6B
PPP1R1B
SERPINB5
FBXO32
PPP1R1B
THBS1
LAMC2
STAC2
ATP1B1
DEGS1
IER3
OGFRL1
GNAS
TFAP2C
CD55
SFRP1
ITGB4
MFGE8
EPHB3
ACTN4
RGS2
PTGS2
SLC2A1
COL9A2
DSP
MDFI
PTP4A1
TNFRSF21
ID4
FURIN
CTNNB1
KLK7
TPM4
TACSTD2
FBLN2
SERPINB5
KLK5
KLK6
RBP1
TPM4
TNFRSF21
RGS2
TFAP2C
ITGA6
COL9A1
SFRP1
FURIN
LAMC2
TACSTD2
MSN
S100B
FBXO32
STAC2
DSP
KRT6B
SERPINB5
ITGB4
FOXI1
EPHB3
MDFI
KLK7
OGFRL1
MFGE8
ACTN4
KLK5
SLC44A2
KLK6
ID4
RBP1
PTP4A1
TMX4
SLC2A1
GNAS
TPM4
TNFRSF21
RGS2
TFAP2C
ITGA6
SFRP1
FURIN
LAMC2
CD55
MSN
S100B
FBXO32
STAC2
KRT6B
FBLN2
SERPINB5
ITGB4
EPHB3
MDFI
KLK7
OGFRL1
MFGE8
ACTN4
KLK5
SLC44A2
KLK6
ID4
RBP1
TMX4
SLC2A1
GNAS
TPM4
RGS2
TFAP2C
ITGA6
ATP1B1
LAMC2
CD55
TACSTD2
CTNNB1
KRT6B
SERPINB5
IER3
ITGB4
KLK7
MFGE8
KLK5
ID4
RBP1
PTP4A1
SLC2A1
TPM4
RGS2
COL9A2
SFRP1
LAMC2
FBLN2
SERPINB5
KLK7
MFGE8
KLK5
ID4
RBP1
SLC2A1